140 related articles for article (PubMed ID: 3909540)
21. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts.
Knott LJ; Levinsky RJ; Newland AC; Jones HM; Linch DC
Clin Exp Immunol; 1985 Dec; 62(3):561-9. PubMed ID: 3910318
[TBL] [Abstract][Full Text] [Related]
23. T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads.
Frame JN; Collins NH; Cartagena T; Waldmann H; O'Reilly RJ; Dupont B; Kernan NA
Transplantation; 1989 Jun; 47(6):984-8. PubMed ID: 2660360
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
Maraninchi D
Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
[No Abstract] [Full Text] [Related]
25. Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation.
Reisner Y; Gan J
Cancer Res; 1985 Sep; 45(9):4026-31. PubMed ID: 2411394
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
27. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
28. Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
Nespoli L; Porta F; Locatelli F; Aversa F; Carotti A; Lanfranchi A; Gibardi A; Marchesi ME; Abate L; Martelli MF
Haematologica; 1990; 75(6):546-50. PubMed ID: 2098297
[TBL] [Abstract][Full Text] [Related]
29. Haploidentical bone marrow transplantation using soybean agglutinin-processed, T-depleted marrow.
Matthay K; Wara DW; Ablin AJ; Cowan MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2678-9. PubMed ID: 3274578
[No Abstract] [Full Text] [Related]
30. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
Irlé C; Kaestli M; Chapuis B; Jeannet M
Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
[TBL] [Abstract][Full Text] [Related]
31. Clonal T-cell colony formation in agar culture: an attractive assay to test the T-cell depletion from bone marrow.
Farcet JP; Beaujean F; Cordonnier C; Pico J; Gourdin MF; Divine M; Bracq C; Bouguet J; Laurent G; Bernard A
Exp Hematol; 1986 Dec; 14(11):1011-4. PubMed ID: 3536543
[TBL] [Abstract][Full Text] [Related]
32. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
Keever CA; Welte K; Sullivan M; O'Reilly RJ
Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
[No Abstract] [Full Text] [Related]
33. Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2735-7. PubMed ID: 3274583
[No Abstract] [Full Text] [Related]
34. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
35. Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk.
Trigg ME; Peterson A; Erickson C; Bozdech M; Billing R; Sondel P; Finlay J; Surfus J; Stuiber M; Hong R
Exp Hematol; 1986 Jan; 14(1):21-6. PubMed ID: 3080322
[TBL] [Abstract][Full Text] [Related]
36. Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
Verdonck LF; Dekker AW; van Heugten H; van Kempen ML; Punt K; de Gast GC
Haematol Blood Transfus; 1987; 30():563-6. PubMed ID: 3305219
[No Abstract] [Full Text] [Related]
37. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
38. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
39. Improved lectin agglutination method for T-cell depletion of HLA-mismatched bone marrow grafts in children.
Schreiner T; Wiesneth M; Slaper-Cortenbach I; Maccari B; Erne E; Bischof C; Müller S; Friedrich W; Kubanek B
Transfus Sci; 1996 Dec; 17(4):637-42. PubMed ID: 10168564
[TBL] [Abstract][Full Text] [Related]
40. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
